United States Patent and Trademark Office

Treace Medical Concepts Announces New Patent Covering Instrumented Bunion Correction Procedures and Milestone 50th U.S. Patent

Retrieved on: 
Thursday, September 14, 2023
1836 U.S. Patent Office fire, Patent, Patient, United States Patent and Trademark Office, Physician, Standard of care, Bunion, United States patent law, Pharmaceutical industry, Treace Medical Concepts

“Our 50th U.S. Patent grant demonstrates our commitment to rapid and meaningful innovation that continues to set the standard in our field,” said John T. Treace, CEO, Founder and Board Member of Treace.

Key Points: 
  • “Our 50th U.S. Patent grant demonstrates our commitment to rapid and meaningful innovation that continues to set the standard in our field,” said John T. Treace, CEO, Founder and Board Member of Treace.
  • “Our pioneering work in the bunion correction space dates back over nine years now.
  • Treace’s innovation continues to advance the standard of care in bunion correction and is recognized by the USPTO, along with patent offices around the world, as novel.
  • The Company encourages investors and potential investors to consult the Treace website regularly for important information about Treace.

Bionik Laboratories Granted United States Patent for Innovative Rehabilitation Technology

Retrieved on: 
Thursday, September 14, 2023
Data Management, Physical Therapy, Technology, Health, General Health, Robotics, Neurology, Health Technology, Software, Internet, Mobile, Wireless, Survivor, Patent, United States Patent and Trademark Office, Stroke, Rehabilitation, Patient, Automation, Pharmaceutical industry, Nursing

This patent, titled "An Apparatus and/or Method for Positioning a Hand for Rehabilitation," marks a significant milestone in Bionik's commitment to progressing robotic technology for rehabilitation.

Key Points: 
  • This patent, titled "An Apparatus and/or Method for Positioning a Hand for Rehabilitation," marks a significant milestone in Bionik's commitment to progressing robotic technology for rehabilitation.
  • The newly granted patent covers groundbreaking technology developed by Bionik that is designed to enhance the rehabilitation process for individuals recovering from neurological injuries and conditions.
  • "The addition of this new patent closes out an almost 4-year patent application process," said Richard Russo, Jr., CEO of Bionik.
  • Bionik has a strong track record of pioneering advancements in the field of robotic assisted rehabilitation, with a focus on improving the lives of patients through innovative technology.

AvaWatz Patents FALCON, A New Trust Assessment and Auto-Correction for AI Models and Machine Learning

Retrieved on: 
Tuesday, September 12, 2023
Patent, Natural language processing, Classification, Correction, United States Patent and Trademark Office, FALCON, Deep learning, Computer vision, Explainable artificial intelligence, Machine learning, Artificial intelligence, Avawatz Mountains, Trust (social science), Medical device

The patent application, titled "Systems and Methods for Trust-Aware Error Detection, Correction, and Explainability in Machine Learning and Computer Vision," introduces the AvaWatz approach to make Machine learning and deep learning models more trustworthy and reliable.

Key Points: 
  • The patent application, titled "Systems and Methods for Trust-Aware Error Detection, Correction, and Explainability in Machine Learning and Computer Vision," introduces the AvaWatz approach to make Machine learning and deep learning models more trustworthy and reliable.
  • The more widely applicable machine learning (ML) and artificial intelligence (AI) get, the more we need to ensure trustworthiness and reliability in the AI/ML model predictions.
  • Earlier this year, AvaWatz applied to patent GENIE and introduced the AvaWatz approach to the difficult issue of training data required to train deep learning and machine learning models.
  • We feel that adopting these novel technologies will help many who work with specialized use cases and need to build customized machine learning applications."

Stuart Therapeutics Announces Issuance of U.S. Patent Covering Ophthalmic Anterior Segment Disorders

Retrieved on: 
Friday, September 8, 2023
Tissue, Glaucoma, Patent, Intellectual property, United States Patent and Trademark Office, Epithelium, Clinical trial, Retina, Inflammation, CMP, Telecanthus, Ophthalmology, Near-sightedness, Therapy, Family, Peptide, Pharmaceutical industry

STUART, Fla., Sept. 8, 2023 /PRNewswire/ -- Stuart Therapeutics, Inc. (Stuart), a clinical-stage ophthalmic biopharmaceutical company focused on developing therapies for the treatment of anterior segment, refractive and posterior segment eye disorders, has announced that the United States Patent and Trademark Office (USPTO) has issued U.S. Patent No. 11,684,651, with granted claims for compositions of matter and methods of use in a variety of anterior segment indications in ophthalmology.   

Key Points: 
  • STUART, Fla., Sept. 8, 2023 /PRNewswire/ -- Stuart Therapeutics, Inc. (Stuart), a clinical-stage ophthalmic biopharmaceutical company focused on developing therapies for the treatment of anterior segment, refractive and posterior segment eye disorders, has announced that the United States Patent and Trademark Office (USPTO) has issued U.S. Patent No.
  • 11,684,651, with granted claims for compositions of matter and methods of use in a variety of anterior segment indications in ophthalmology.
  • Stuart controls the rights to this technology for human therapeutic use in ophthalmology through a prior agreement with the patent owner, Sustain Holdings, LLC.
  • The newly granted patent claims expand Stuart's intellectual property in ophthalmic anterior segment diseases and disorders.

USPTO Grants Shooter Detection Systems Two New Patents for Innovative Gunshot Detection Solutions

Retrieved on: 
Thursday, September 7, 2023
Patent, Maintenance, ALRM, United States Patent and Trademark Office, SDS, Research, Engineering, United States Secretary of Homeland Security, Alarm.com, Interior design, Satellite navigation device, Northeastern University

ROWLEY, Mass., Sept. 7, 2023 /PRNewswire-PRWeb/ -- Shooter Detection Systems (SDS), an Alarm.com (NASDAQ: ALRM) company and the world's premier gunshot detection solutions provider, proudly announces the United States Patent and Trademark Office (USPTO) has granted two additional patents to its portfolio of indoor gunshot detection technologies, Patent No. US 11,604,248 (Low Power Gunshot Sensor Testing) and Patent No. US 11,688,414 (Low Power Gunshot Detection).

Key Points: 
  • ROWLEY, Mass., Sept. 7, 2023 /PRNewswire-PRWeb/ -- Shooter Detection Systems (SDS), an Alarm.com (NASDAQ: ALRM) company and the world's premier gunshot detection solutions provider, proudly announces the United States Patent and Trademark Office (USPTO) has granted two additional patents to its portfolio of indoor gunshot detection technologies, Patent No.
  • US 11,688,414 (Low Power Gunshot Detection).
  • The team has developed a groundbreaking approach to leverage SDS's expertise in infrared detection technologies to significantly reduce battery usage in future indoor gunshot detection sensors.
  • SDS invites its partners, customers, and competitors to view all of SDS' gunshot detection innovations on the company's patents page.

Antion Announces Granting of Key Technology Patent in the United States

Retrieved on: 
Wednesday, September 6, 2023
United States Patent and Trademark Office, Gene silencing, Patent, IP, Antion, Fine chemical

GENEVA, Sept. 06, 2023 (GLOBE NEWSWIRE) -- Antion Biosciences SA (Antion), an innovative developer of cell and gene therapy technologies, is pleased to announce the granting of a significant patent by the United States Patent and Trademark Office (USPTO).

Key Points: 
  • GENEVA, Sept. 06, 2023 (GLOBE NEWSWIRE) -- Antion Biosciences SA (Antion), an innovative developer of cell and gene therapy technologies, is pleased to announce the granting of a significant patent by the United States Patent and Trademark Office (USPTO).
  • The awarded patent, identified as US Patent No.
  • US 11,649,455, further strengthens Antion's position as a leading innovator in the cell and gene therapy field.
  • Together with its founding IP (US 9,556,433), the newly granted patent solidifies Antion’s protection over its uniquely optimized gene silencing technologies.

Revolutionizing AI Computation: Introducing Custom Mass Multiplication Circuits

Retrieved on: 
Wednesday, September 6, 2023
Software, Hardware, Start-Up, Artificial Intelligence, Robotics, Professional Services, Technology, Semiconductor, Graphics processing unit, HD, Patent, TPU, United States Patent and Trademark Office, MAK Technologies, Inc., Intelligence, CNN Pipeline, Multimedia, FPS, Machine learning, Computer data storage, Gigantor, AI

Gigantor Technologies Inc — In a groundbreaking leap forward for artificial intelligence and computational efficiency, the United States Patent and Trademark Office (USPTO) has officially approved Patent Number 11,748,061, detailing the innovative Custom Mass Multiplication Circuits.

Key Points: 
  • Gigantor Technologies Inc — In a groundbreaking leap forward for artificial intelligence and computational efficiency, the United States Patent and Trademark Office (USPTO) has officially approved Patent Number 11,748,061, detailing the innovative Custom Mass Multiplication Circuits.
  • Gigantor's newly patented Mass Multiplier technology bypasses these constraints by implementing a unique non-Von Neumann approach.
  • By integrating massive arrays of calculations into a unified process, the Custom Mass Multiplication Circuits harness the power of collective computation, enabling calculations that dwarf even the most advanced GPUs and TPUs in the market.
  • The capability to harness vast computational power without compromising performance is ushering in a new era of AI advancements.

HCW Biologics Participating at H.C. Wainwright 25th Annual Global Investment Conference in New York on September 11 – 13, 2023

Retrieved on: 
Wednesday, September 6, 2023
Anantara New York Palace Budapest Hotel, Pancreatic cancer, Patent, Masonic Cancer Center, University, University of Minnesota, United States Patent and Trademark Office, Clinical trial, Cancer, Ageing, Gynecologic Oncology (journal), Research, Inflammation, Cell, MRC Laboratory of Molecular Biology, EDT, Trial of the century, Drug resistance, Molecular biology, National Cancer Institute, Professor, Patient, Division, Colorectal cancer, Department of Obstetrics and Gynecology (Massachusetts General Hospital), Immune system, Gynaecology, UMN, Principal, Lotte New York Palace Hotel, NCI, Notifiable disease, Immunosuppression, Natural killer T cell, Laboratory, Conference, Pharmaceutical industry, Vaccine, Obstetrics

On September 12, 2023, the Company will be meeting individual investors in person at the conference venue, the Lotte New York Palace Hotel in New York.

Key Points: 
  • On September 12, 2023, the Company will be meeting individual investors in person at the conference venue, the Lotte New York Palace Hotel in New York.
  • In addition, a pre-recorded, virtual Company update will be available on demand beginning at 7:00 a.m. EDT on September 11, 2023 for all who register for the conference.
  • Due to clinical protocol requirements, dosing of the remaining patients is expected to take place in the next 3 to 6 months.
  • Dr. Geller stated, “Our team is very excited to bring this clinical trial to patients who have recurrent cancer.

NordVPN launches NordLabs to boost innovation in experimental technologies

Retrieved on: 
Thursday, August 31, 2023
Patent, United States Patent and Trademark Office, AI, Privacy, Internet, NordVPN

LONDON, Aug. 31, 2023 /PRNewswire/ -- NordVPN, a leading cybersecurity company, launches NordLabs – a platform for experimental projects and cutting-edge innovations. It will explore emerging technologies, such as AI, to create new tools and services. Signed up users can expect the first products to test in September.

Key Points: 
  • LONDON, Aug. 31, 2023 /PRNewswire/ -- NordVPN, a leading cybersecurity company, launches NordLabs – a platform for experimental projects and cutting-edge innovations.
  • "New emerging technologies raise challenges for cybersecurity, privacy, and internet freedom, but at the same time, they bring new opportunities.
  • NordLabs will allow us to have additional flexibility when it comes to the development of experimental tools and services.
  • Once new experimental projects are released, registered users can test and provide feedback on features and services developed by NordVPN.

Brown Venture Group Invests in Big Navajo Energy

Retrieved on: 
Tuesday, August 29, 2023
Patent, Fintech, Partnership, Hydrogen, United States Patent and Trademark Office, Crunchbase, Black, Tech, Campbell, Natural Resources, Native Americans, NASA, Indian country, Growth, Health, Software, Renewable energy, Cryptocurrency, Latinx

MINNEAPOLIS, Aug. 29, 2023 /PRNewswire/ -- Brown Venture Group LLC, a Black-owned venture capital firm formed to fund Indigenous, Black, and Latinx technology entrepreneurs, has committed significant financial resources to foster the growth of Big Navajo Energy, which is a Navajo-owned and operated company focused on the development and deployment of clean and renewable energy solutions for tribal and rural communities.

Key Points: 
  • MINNEAPOLIS, Aug. 29, 2023 /PRNewswire/ -- Brown Venture Group LLC , a Black-owned venture capital firm formed to fund Indigenous, Black, and Latinx technology entrepreneurs, has committed significant financial resources to foster the growth of Big Navajo Energy, which is a Navajo-owned and operated company focused on the development and deployment of clean and renewable energy solutions for tribal and rural communities.
  • "Big Navajo Energy has spent the past decade bringing clean energy solutions to tribal communities throughout North America and this investment by Brown Venture Group will assist us in continuing to build that self-sufficient ecosystem in order to address energy challenges faced not only by our communities but by rural areas overall," said Dory Peters, president and CEO of Big Navajo Energy.
  • "Big Navajo Energy has spent the past decade bringing clean energy solutions to tribal communities throughout North America and this investment by Brown Venture Group will assist us in continuing to build that self-sufficient ecosystem in order to address energy challenges faced not only by our communities but by rural areas overall," said Dory Peters, president and CEO of Big Navajo Energy.
  • "Indigenous nations are one of the most underfunded communities with the most upside potential of any group of contributors in America and Brown Venture Group is excited to support the innovations of Big Navajo Energy," said Paul Campbell, co-founder and managing partner of Brown Venture Group.